openPR Logo
Press release

Middle East Respiratory Syndrome (MERS) Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results | Inovio Pharmaceuticals Inc.

Middle East Respiratory Syndrome (MERS) Therapeutics-

Middle East respiratory syndrome (MERS) is a viral respiratory disease caused by a coronavirus (MERS-CoV). Coronaviruses are a type of viruses that affect the respiratory tract of mammals, including humans.

Download the sample report @ https://www.pharmaproff.com/request-sample/1066

Human coronaviruses usually cause mild to moderate cold-like illnesses. However, MERS-CoV is different from any other coronavirus previously found in people. The infected patients may have mild symptoms or no symptoms at all, but most people infected with MERS-CoV develop severe respiratory illness, fever, cough, and shortness of breath.

Get the detailed analysis @ https://www.pharmaproff.com/report/mers-therapeutics-pipeline-analysis

Some patients have reported to have gastrointestinal symptoms like diarrhea and nausea/vomiting; and kidney failure. MERS-CoV is known to spread from an infected person to others through respiratory secretions like coughing.

Make enquiry before purchase @ https://www.pharmaproff.com/enquiry/1066

However, the precise way in which this virus spreads has not been well understood yet. Some of the companies having drugs in the MERS syndrome pipeline includes Atriva Therapeutics GmbH and Inovio Pharmaceuticals Inc. are known to be involved in MERS pipeline.

• The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
• Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Middle East Respiratory Syndrome (MERS) Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results | Inovio Pharmaceuticals Inc. here

News-ID: 1755710 • Views: 1637

More Releases for MERS

Global Middle East Respiratory Syndrome (MERS) - Pipeline Review, H1 2018 Market …
The examination report Worldwide Middle East Respiratory Syndrome (MERS) Market is a market consider looking at and profiling the present state of the Middle East Respiratory Syndrome (MERS) business in a professional way. The report systematically categorizes the Middle East Respiratory Syndrome (MERS) showcase, clarifying the meaning of Middle East Respiratory Syndrome (MERS) before clarifying the classification of the market by the different parameters utilized by advertise specialists. The different
Middle East Respiratory Syndrome (MERS) Market size and company share data
MarketResearchReports.Biz adds “Middle East Respiratory Syndrome (MERS) Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Respiratory Syndrome (MERS) market and the growth estimates for the forecasted period. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Middle East Respiratory Syndrome (MERS) - Pipeline Review, H1 2018, provides an overview of the Middle East Respiratory Syndrome (MERS) (Infectious
Respiratory Syndrome (MERS) –Pharmaceutical & Healthcare disease Pipeline Anal …
HTF Market Report released a new research document of 67 pages on industry titled as 'Middle East Respiratory Syndrome (MERS) - Pipeline Review, H1 2018' with detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes important players/vendors such as Kineta , NanoViricides, Novavax , Phelix Therapeutics LLC, Regeneron Pharmaceuticals etc The report will help you gain market insights, future trends and growth prospects for forecast
Middle East Respiratory Syndrome (MERS) Industry Anticipated To Witness Notewort …
Overview Middle East respiratory syndrome (MERS) is a viral respiratory disease caused by a coronavirus (MERS-CoV). Symptoms include fever, cough and shortness of breath. Other symptoms include nausea, vomiting and diarrhea. Pneumonia is common, and sometimes it cause injury to organs, such as the kidneys. Treatment is aimed at relieving symptoms (joint pain and fever) with fluids and medications.  Click here for sample report @ http://www.wiseguyreports.com/sample-request/2740060-middle-east-respiratory-syndrome-mers-pipeline-review-h2-2017 Report Highlights The Pharmaceutical and Healthcare latest pipeline
Middle East Respiratory Syndrome (MERS) - Industry Analysis, Trends, and Forecas …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Middle East Respiratory Syndrome (MERS) - Pipeline Review, H1 2017” to its report offerings. The report covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1196659 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Middle East Respiratory Syndrome (MERS) - Pipeline
New market study on "Middle East Respiratory Syndrome (MERS) - Pipeline Review, …
Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Middle East Respiratory Syndrome Pipeline Review, H2 2016, provides an overview of the Middle East Respiratory Syndrome (Infectious Disease) pipeline landscape. Middle East respiratory syndrome (MERS) is a viral respiratory disease caused by a coronavirus (MERSCoV). Symptoms include fever, cough and shortness of breath. Other symptoms include nausea, vomiting and diarrhea. Pneumonia is common, and sometimes it cause injury to organs,